Skip to main content

Find Clinical Trials

Home
Conditions
Neoplasms, Plasma Cell

Clinical trial condition

Neoplasms, Plasma Cell

Explore clinical trials studying Neoplasms, Plasma Cell. Study availability and eligibility vary by location and protocol.

517 public trials 54 recruiting studies

Refine in advanced search Browse all conditions

Neoplasms, Plasma Cell trial results

Completed

Darbepoetin Alfa Administered Once Every 4 Weeks in the Treatment of Subjects With Anemia of Cancer

NCT00095277

Conditions: Anemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +3 more
Locations: Not specified

View Trial Details

Completed

Study of High-Dose Melphalan and Autologous Stem Cell Transplantation in Patients With Primary Light Chain Amyloidosis

NCT00017680

Conditions: Amyloidosis, Arthritis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +24 more
Locations: Herbert Irving Comprehensive Cancer Center New York, United States

View Trial Details

Completed

HLA-Mismatched Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Hematological Malignancies

NCT00001748

Conditions: Bone Marrow Diseases, Chronic Disease, Disease Attributes, +25 more
Locations: National Heart, Lung and Blood Institute (NHLBI) Bethesda, Maryland, United States

View Trial Details

Completed

Protein Tyrosine Kinases (PTK) in Multiple Myeloma

NCT00165347

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Melphalan, Prednisone, Thalidomide And Bortezomib In Advanced And Refractory Multiple Myeloma Patients

NCT00358020

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Divisione Di Ematologia, Ospedale Centrale Bolzano, BOLZANO, Italy

Unità Operativa Complessa Di Ematologia, Presidio Ospedaliero Dell'Annunziata, Azienda Ospedaliera Di Cosenza Cosenza, COSENZA, Italy

Divisione Di Ematologia E Trapianto Di Midollo Osseo, Azienda Ospedaliera Cervello Palermo, PALERMO, Italy

Divisione Di Ematologia, Ospedali Riuniti Reggio Calabria, Italy

View Trial Details

Completed

A Study of Motexafin Gadolinium for the Treatment of Relapsed or Refractory Multiple Myeloma

NCT00096837

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Robert H. Lurie Comprehensive Cancer Center Chicago, Illinois, United States

View Trial Details

Withdrawn

CD70.CAR for CD70+ Lymphoma, Myeloma and Solid Tumors

NCT07297160

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hematologic Diseases, +23 more
Locations: Texas Children's Hospital Houston, Texas, United States

The Methodist Hospital Houston, Texas, United States

View Trial Details